Guardant Health
GH
#3260
Rank
HK$28.00 B
Marketcap
HK$226.62
Share price
-3.64%
Change (1 day)
29.90%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of September 2024 : -HK$0.47 Billion

According to Guardant Health 's latest financial reports the company has -HK$0.47 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$HK$1.23 B163.57%
2022-12-31$HK$0.47 B-90.65%
2021-12-31$HK$5.02 B-52.14%
2020-12-31$HK$10.50 B59.12%
2019-12-31$HK$6.60 B60.65%
2018-12-31$HK$4.11 B70.5%
2017-12-31$HK$2.41 B290.15%
2016-12-31$HK$0.61 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
HK$6.51 B-1,491.97%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$24.40 B-5,316.97%๐Ÿ‡บ๐Ÿ‡ธ USA